在早期诊断和治疗早产的近期进展和挑战
Prashil Gondane1, Sakshi Kumbhakarn1, Pritiprasanna Maity2
1Department of Medical Devices, National Institute of Pharmaceutical Education and Research Kolkata, 168, Maniktala Main Road, Kankurgachi, Kolkata 700054, India.
Bioengineering (Basel, Switzerland)
|February 23, 2024
概括
过早分娩 (PTB) 是导致婴儿死亡的主要原因. 本综述涵盖了风险因素,早期检测方法,如多omics和AI/ML,以及PTB的护理点测试.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿医学 新生儿医学
- 生物标志物发现发现
背景情况:
- 早产 (PTB) 是新生儿死亡率和长期婴儿残疾的主要原因.
- 导致PTB的复杂且往往未知的机制阻碍了及时诊断和干预.
- 早期检测对于管理和预防与PTB相关的不良结果至关重要.
研究的目的:
- 提供关于早产风险因素的全面概述.
- 审查用于早期检测PTB的传统和先进方法.
- 讨论PTB诊断的新兴技术和挑战.
主要方法:
- 关于PTB风险因素,诊断程序和治疗措施的文献综述.
- 探索用于早期检测的多omics和人工智能/机器学习 (AI/ML) 方法.
- 使用横流免疫试验和微流体芯片分析蛋白质生物标记物检测原理.
主要成果:
- 确定了与早产相关的已知风险因素.
- 评估了传统和先进的PTB检测策略,包括多omics和AI/ML.
- 讨论了侧流免疫试验和微流体芯片用于蛋白质生物标志物检测的应用.
- 检查了PTB和其局限性的商业可用的临床检测 (POCT) 设备.
结论:
- 由于复杂的潜在机制,早期发现PTB仍然是一个重大挑战.
- 先进的技术,如多omics,AI/ML,和新的生物标志物检测平台显示改善PTB诊断的承诺.
- 需要进一步开发和验证POCT设备,以克服PTB管理中的当前挑战.
更多相关视频
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...


